Shkreli resigns as Turing CEO after securities fraud arrest
TRENTON, N.J. - Martin Shkreli, the pharmaceutical executive arrested Thursday on charges of securities fraud, has resigned as the head of one of the companies he runs, Turing Pharmaceuticals.
He's being replaced on an interim basis by Ron Tilles, who has been chairman of Turing's board of directors since the company was founded late last year. In a statement Friday, Turing said that Tilles will continue to hold the board chairman position as well.
Tilles has worked at numerous private equity and venture capital firms in the pharmaceutical and medical device industries over the last two decades.
Shkreli has become the "most hated man in America," according to some headline writers, for jacking up the price of a life-saving drug by 5,000 percent after acquiring rights to it.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Sen. Troy Brown will spend the weekend in jail
Spanish Town Parade asks for usual irreverence but inclusion
Residents on edge as Comite River crests above flood stage
Baton Rouge residents gather to watch Trump's inauguration
Police believe illegal immigrant could be tied to other sex crimes